Security report for angelinipharma.sk

Angelini Pharma Slovenská republika, s.r.o. operates a professional pharmaceutical website focused on central nervous system (CNS) disorders, pain management, rare diseases, and consumer health products. The company is positioned as a leading player in these sectors within Slovakia and broader European markets, supported by its parent company Angelini S.p.a. The website provides comprehensive corporate information, research and development insights, and product details tailored to healthcare professionals and consumers. The presence of multiple country-specific Angelini Pharma domains indicates a broad regional footprint. Technically, the website employs modern JavaScript libraries such as jQuery, Slick Carousel, and Magnific Popup, alongside privacy-focused analytics via Piwik PRO. The site is well-optimized for mobile devices and demonstrates good SEO practices. Hosting and resource domains are consistent with the Angelini corporate group, and asynchronous script loading supports moderate performance. From a security perspective, the site enforces HTTPS and implements cookie consent mechanisms aligned with GDPR requirements. However, explicit security headers and published security policies or incident response information are absent, representing areas for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The WHOIS data indicates privacy protection for domain registration, which is justified for this business type and does not raise legitimacy concerns. Overall, the website is professional, trustworthy, and compliant with privacy regulations, though it could enhance its security posture by publishing explicit policies and improving header configurations. The lack of direct contact emails or phone numbers on the site is noted but does not significantly detract from credibility given the corporate nature and presence of physical address and social media channels.